Statistics on Biotechnology Use  
Results by sector of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Unidades: specified in variables

;Total;Units;P.A.;Higher Education;PNPI;
Units that perform R+D in Biotechnology;1.289;1.079;141;58;11;
%Units according to biotechnology used: Genetic code;44;35;91;93;55;
%Units according to biotechnology used: Functional units;51;44;82;98;46;
%Units according to biotechnology used: Cellular and tissue culturing and engineering;34;26;68;88;64;
%Units according to biotechnology used: Bioprocesses;52;49;55;91;27;
%Units according to biotechnology used: Sub-cellular organisms;16;8;47;71;36;
%Units according to biotechnology used: Bio-computing;30;23;60;86;27;
%Units according to biotechnology used: Nanobiotechnology;20;15;38;67;9;
%Units according to biotechnology used: Other;12;12;13;12;.;
Units in which biotechnology activities are:  Main and/or exclusive;571;519;40;3;9;
Units in which biotechnology activities are: A secondary line of business;260;179;41;40;.;
Units in which biotechnology activities are: A tool necessary for production;458;381;60;15;2;
%Units by field(s) of ultimate application of biotechnology use: Human health;53;48;76;93;82;
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;22;21;17;55;9;
%Units by field(s) of ultimate application of biotechnology use: Food products;34;33;24;81;9;
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;23;22;18;69;27;
%Units by field(s) of ultimate application of biotechnology use: Environment;20;17;16;72;.;
%Units by field(s) of ultimate application of biotechnology use: Industry;17;15;12;74;.;
Personnel in R&D in biotechnology (no. of persons);34.060;9.795;12.138;11.848;279;
Personnel in R&D in biotechnology (no. of persons): Researchers;22.385;5.573;7.470;9.117;225;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;11.675;4.222;4.668;2.731;54;
Personnel in R&D in biotechnology (no. of persons): women;18.456;5.298;7.068;5.917;173;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;11.274;2.925;3.864;4.350;135;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;7.182;2.373;3.204;1.567;38;
Personnel in R&D in biotechnology (FTE);23.664,3;6.828,6;9.456,2;7.281,1;98,4;
Personnel in R&D in biotechnology (FTE): Researchers;15.134,4;4.106,5;5.437,8;5.526,3;63,8;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;8.529,9;2.722,1;4.018,4;1.754,8;34,6;
Personnel in R&D in biotechnology (FTE): women;13.233,6;3.811,7;5.622,5;3.725;74,4;
Personnel in R&D in biotechnology (FTE): (women) Researchers;7.820,7;2.190,7;2.885,9;2.699,8;44,3;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;5.412,9;1.621;2.736,6;1.025,2;30,1;
Internal expenditure on R&D (thousands of euros);1.450.426;533.826;553.526;357.077;5.998;
1) By nature of the expense: Current expenses;1.345.487;492.955;528.602;318.459;5.470;
1.1) Remuneration to researchers;612.335;203.439;207.991;198.908;1.997;
1.2) Remuneration to technicians and assistants;261.758;96.850;119.932;44.005;971;
1.3) Other current expenses;471.394;192.666;200.679;75.547;2.502;
2) By nature of the expense: Capital expenses;104.939;40.870;24.924;38.617;527;
2.1) Land and buildings;25.473;7.521;1.585;16.062;305;
2.2) Equipment and instruments;75.530;32.078;22.111;21.131;210;
2.3) Acquisition of specific R+D software;3.936;1.270;1.228;1.424;13;
1) By origin of the funds: National funds;1.280.003;432.869;510.176;331.233;5.725;
1.1) Own funds;460.825;319.046;66.029;74.512;1.238;
1.2) From companies;113.547;39.253;47.227;24.742;2.324;
1.3) Public Administration funds;675.417;70.063;379.086;225.082;1.185;
1.4) From Universities;4.236;156;3.197;819;65;
1.5) From non profit private institutions;25.979;4.351;14.637;6.078;912;
1) By origin of the funds: Foreign funds;170.423;100.956;43.351;25.843;273;
2.1) From EU programmes;77.465;20.070;36.920;20.376;99;
2.2) Other foreign funds;92.959;80.886;6.431;5.467;174;
Purchase of services R & D in Biotechnology to (thousands of euros);162.538;138.625;23.594;278;41;
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;123.047;101.114;21.615;278;41;
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;39.491;37.512;1.979;.;.;
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;48;46;59;57;46;
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;13;13;16;14;18;
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;17;12;48;35;9;
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;16;14;21;31;9;
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;21;19;28;43;27;
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;21;19;28;38;36;
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;18;18;18;12;18;
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;36;37;37;26;18;
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;50;49;50;55;55;
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;19;19;21;16;18;
%Units that have requested biotechnology patents in Biotechnology;21;15;45;74;.;
Number of patents requested;1.729;466;685;578;.;
Notas:

.
'..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total units from other sectors with activities  in R&D in Biotechnology
Fuente: National Statistics Institute